OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives
Eleonora De Matteis, Martina Guglielmetti, Raffaele Ornello, et al.
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 6, pp. 627-641
Closed Access | Times Cited: 60
Eleonora De Matteis, Martina Guglielmetti, Raffaele Ornello, et al.
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 6, pp. 627-641
Closed Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
Hans‐Christoph Diener, Cristina Tassorelli, David W. Dodick, et al.
Cephalalgia (2020) Vol. 40, Iss. 10, pp. 1026-1044
Open Access | Times Cited: 147
Hans‐Christoph Diener, Cristina Tassorelli, David W. Dodick, et al.
Cephalalgia (2020) Vol. 40, Iss. 10, pp. 1026-1044
Open Access | Times Cited: 147
Structural and Functional Brain Changes in Migraine
Sait Ashina, Enrico Bentivegna, Paolo Martelletti, et al.
Pain and Therapy (2021) Vol. 10, Iss. 1, pp. 211-223
Open Access | Times Cited: 73
Sait Ashina, Enrico Bentivegna, Paolo Martelletti, et al.
Pain and Therapy (2021) Vol. 10, Iss. 1, pp. 211-223
Open Access | Times Cited: 73
Pain persists in mice lacking both Substance P and CGRPα signaling
Donald Iain MacDonald, Monessha Jayabalan, Jonathan Seaman, et al.
eLife (2025) Vol. 13
Open Access | Times Cited: 1
Donald Iain MacDonald, Monessha Jayabalan, Jonathan Seaman, et al.
eLife (2025) Vol. 13
Open Access | Times Cited: 1
Early outcomes of migraine after erenumab discontinuation: data from a real-life setting
Eleonora De Matteis, Giannapia Affaitati, Ilaria Frattale, et al.
Neurological Sciences (2021) Vol. 42, Iss. 8, pp. 3297-3303
Closed Access | Times Cited: 55
Eleonora De Matteis, Giannapia Affaitati, Ilaria Frattale, et al.
Neurological Sciences (2021) Vol. 42, Iss. 8, pp. 3297-3303
Closed Access | Times Cited: 55
Association between response to triptans and response to erenumab: real-life data
Ilaria Frattale, Valeria Caponnetto, Alfonsina Casalena, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 50
Ilaria Frattale, Valeria Caponnetto, Alfonsina Casalena, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 50
A Bidirectional View of Migraine and Diet Relationship
Parisa Gazerani
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 435-451
Open Access | Times Cited: 50
Parisa Gazerani
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 435-451
Open Access | Times Cited: 50
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
Simona Sacco, Christian Lampl, Antoinette MaassenVanDenBrink, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 49
Simona Sacco, Christian Lampl, Antoinette MaassenVanDenBrink, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 49
Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine—Clinical Considerations: A Narrative Review
Jessica Ailani, Eric A. Kaiser, Paul G. Mathew, et al.
Neurology (2022) Vol. 99, Iss. 19, pp. 841-853
Open Access | Times Cited: 37
Jessica Ailani, Eric A. Kaiser, Paul G. Mathew, et al.
Neurology (2022) Vol. 99, Iss. 19, pp. 841-853
Open Access | Times Cited: 37
Menstrually associated migraine
Eleonora De Matteis, Raffaele Ornello, Simona Sacco
Handbook of clinical neurology (2024), pp. 331-351
Closed Access | Times Cited: 6
Eleonora De Matteis, Raffaele Ornello, Simona Sacco
Handbook of clinical neurology (2024), pp. 331-351
Closed Access | Times Cited: 6
Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
Raffaele Ornello, Alfonsina Casalena, Ilaria Frattale, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 41
Raffaele Ornello, Alfonsina Casalena, Ilaria Frattale, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 41
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine
Damiana Scuteri, Paolo Tonin, Pierluigi Nicotera, et al.
Toxins (2022) Vol. 14, Iss. 8, pp. 529-529
Open Access | Times Cited: 28
Damiana Scuteri, Paolo Tonin, Pierluigi Nicotera, et al.
Toxins (2022) Vol. 14, Iss. 8, pp. 529-529
Open Access | Times Cited: 28
The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
Xinyu Tao, Zeya Yan, Jiahao Meng, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Xinyu Tao, Zeya Yan, Jiahao Meng, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Refractory migraine
Г. Р. Табеева, O. V. Kosivtsova, N. A. Kovalchuk, et al.
Neurology neuropsychiatry Psychosomatics (2024) Vol. 16, Iss. 2, pp. 76-86
Open Access | Times Cited: 5
Г. Р. Табеева, O. V. Kosivtsova, N. A. Kovalchuk, et al.
Neurology neuropsychiatry Psychosomatics (2024) Vol. 16, Iss. 2, pp. 76-86
Open Access | Times Cited: 5
OnabotulinumtoxinA: Still the Present for Chronic Migraine
Carlo Baraldi, Flavia Lo Castro, Raffaele Ornello, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 59-59
Open Access | Times Cited: 12
Carlo Baraldi, Flavia Lo Castro, Raffaele Ornello, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 59-59
Open Access | Times Cited: 12
Perceived ease-of-usability and local tolerability using CGRP monoclonal antibody autoinjectors <i>vs.</i> syringes: an online questionnaire-based study in patients with migraine
Marcello Silvestro, Pasquale Sozio, Ilaria Orologio, et al.
Confinia Cephalalgica (2025) Vol. 34, Iss. 2
Closed Access
Marcello Silvestro, Pasquale Sozio, Ilaria Orologio, et al.
Confinia Cephalalgica (2025) Vol. 34, Iss. 2
Closed Access
Pain persists in mice lacking both Substance P and CGRPα signaling
Donald Iain MacDonald, Monessha Jayabalan, Jonathan Seaman, et al.
(2025)
Open Access
Donald Iain MacDonald, Monessha Jayabalan, Jonathan Seaman, et al.
(2025)
Open Access
Ditans and Gepants: hope or false promise for menstrual migraine?
Gonçalo Cabral
Neurological Sciences (2025)
Closed Access
Gonçalo Cabral
Neurological Sciences (2025)
Closed Access
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
Damiana Scuteri, Maria Tiziana Corasaniti, Paolo Tonin, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Damiana Scuteri, Maria Tiziana Corasaniti, Paolo Tonin, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Comparative Efficacy of Oral Calcitonin-Gene–Related Peptide Antagonists for the Treatment of Acute Migraine: Updated Meta-analysis
Dong Kyoung Ha, Min Ji Kim, Nayoung Han, et al.
Clinical Drug Investigation (2021) Vol. 41, Iss. 2, pp. 119-132
Closed Access | Times Cited: 25
Dong Kyoung Ha, Min Ji Kim, Nayoung Han, et al.
Clinical Drug Investigation (2021) Vol. 41, Iss. 2, pp. 119-132
Closed Access | Times Cited: 25
Acute Migraine: Can the New Drugs Clinically Outpace?
Alok Singh, Dhyuti Gupta, Ajaya Kumar Sahoo
SN Comprehensive Clinical Medicine (2020) Vol. 2, Iss. 8, pp. 1132-1138
Closed Access | Times Cited: 25
Alok Singh, Dhyuti Gupta, Ajaya Kumar Sahoo
SN Comprehensive Clinical Medicine (2020) Vol. 2, Iss. 8, pp. 1132-1138
Closed Access | Times Cited: 25
Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
Raffaele Ornello, Ilaria Frattale, Valeria Caponnetto, et al.
Brain Sciences (2021) Vol. 11, Iss. 3, pp. 370-370
Open Access | Times Cited: 21
Raffaele Ornello, Ilaria Frattale, Valeria Caponnetto, et al.
Brain Sciences (2021) Vol. 11, Iss. 3, pp. 370-370
Open Access | Times Cited: 21
Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis
Karissa Johnston, Evan Popoff, Alison Deighton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2021) Vol. 22, Iss. 1, pp. 155-166
Open Access | Times Cited: 21
Karissa Johnston, Evan Popoff, Alison Deighton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2021) Vol. 22, Iss. 1, pp. 155-166
Open Access | Times Cited: 21
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data
Simona Guerzoni, Carlo Baraldi, Umberto Pensato, et al.
Neurological Sciences (2022) Vol. 43, Iss. 6, pp. 3823-3830
Closed Access | Times Cited: 16
Simona Guerzoni, Carlo Baraldi, Umberto Pensato, et al.
Neurological Sciences (2022) Vol. 43, Iss. 6, pp. 3823-3830
Closed Access | Times Cited: 16
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Pain and Therapy (2021) Vol. 10, Iss. 1, pp. 637-650
Open Access | Times Cited: 18
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Pain and Therapy (2021) Vol. 10, Iss. 1, pp. 637-650
Open Access | Times Cited: 18
Combination therapy in migraine: asset or issue?
Paolo Martelletti
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 10, pp. 995-996
Open Access | Times Cited: 19
Paolo Martelletti
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 10, pp. 995-996
Open Access | Times Cited: 19
